Your browser doesn't support javascript.
loading
Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastoma.
Guo, Gao; Gong, Ke; Puliyappadamba, Vineshkumar Thidil; Panchani, Nishah; Pan, Edward; Mukherjee, Bipasha; Damanwalla, Ziba; Bharia, Sabrina; Hatanpaa, Kimmo J; Gerber, David E; Mickey, Bruce E; Patel, Toral R; Sarkaria, Jann N; Zhao, Dawen; Burma, Sandeep; Habib, Amyn A.
Affiliation
  • Guo G; Department of Neurology and Neurotherapeutics, Division of Hematology-Oncology, Dallas, Texas.
  • Gong K; Department of Neurology and Neurotherapeutics, Division of Hematology-Oncology, Dallas, Texas.
  • Puliyappadamba VT; Department of Radiation Oncology, Division of Hematology-Oncology, Dallas, Texas.
  • Panchani N; Department of Pathology, Division of Hematology-Oncology, Dallas, Texas.
  • Pan E; Department of Neurology and Neurotherapeutics, Division of Hematology-Oncology, Dallas, Texas.
  • Mukherjee B; Department of Radiation Oncology, Division of Hematology-Oncology, Dallas, Texas.
  • Damanwalla Z; Department of Neurology and Neurotherapeutics, Division of Hematology-Oncology, Dallas, Texas.
  • Bharia S; Department of Neurology and Neurotherapeutics, Division of Hematology-Oncology, Dallas, Texas.
  • Hatanpaa KJ; Department of Radiation Oncology, Division of Hematology-Oncology, Dallas, Texas.
  • Gerber DE; Department of Pathology, Division of Hematology-Oncology, Dallas, Texas.
  • Mickey BE; Department of Internal Medicine, Division of Hematology-Oncology, Dallas, Texas.
  • Patel TR; Harold C. Simmons Comprehensive Cancer Center, VA North Texas Health Care System, Dallas, Texas.
  • Sarkaria JN; Department of Neurosurgery, VA North Texas Health Care System, Dallas, Texas.
  • Zhao D; Department of Neurosurgery, VA North Texas Health Care System, Dallas, Texas.
  • Burma S; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.
  • Habib AA; Departments of Biomedical Engineering and Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Neuro Oncol ; 21(12): 1529-1539, 2019 12 17.
Article in En | MEDLINE | ID: mdl-31363754
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Gene Expression Regulation, Neoplastic / Tumor Necrosis Factor-alpha / Glioblastoma / Drug Resistance, Neoplasm Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2019 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Gene Expression Regulation, Neoplastic / Tumor Necrosis Factor-alpha / Glioblastoma / Drug Resistance, Neoplasm Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2019 Document type: Article Country of publication: United kingdom